🚨 Big news for the #SCN2A community 🚨

Landmark UCSF study shows CRISPR activation can restore SCN2A function — even later in development. A real step forward, and real hope, for families living with SCN2A-related disorders. www.prnewswire.com/news-release...

We're proud to celebrate the opening of the #SCN2A / #SCN8A Multidisciplinary Clinic at Children’s Hospital Colorado, led by Dr. Megan Abbott.
This clinic represents hope, progress, and a new chapter of support for our community.
www.scn2a.org/news.html
💜💚💙

📣 Please join us in congratulating Jennifer Kearney, PhD as this year’s MDBR awardee! Dr. Kearney created the first ever #SCN2a mouse model & also serves on the Foundation’s SAB.

Thank you riders, volunteers and donors!

Read more here: www.orphandiseasecenter.med.upenn.edu/awarded-gran...

The much-anticipated recap of our experience at the #AES2024 is here! Check out how we kept #SCN2A front and center throughout this 4-day event!

👉 Read the full summary here: www.scn2a.org/AES-2024-Rec...

👉 Donate here: secure.qgiv.com/event/givesc...

💜💙💚

#CureSCN2A #GiftOfHope

Our team proudly represented the #SCN2A community at #AES2024! Over 4 days, we worked tirelessly to spread awareness, educate, and collaborate on advancing care and treatments for SCN2A-related disorders.
Each meeting and conversation reinforced the power of collaboration in driving progress!

We look forward to seeing you soon!

JUST PUBLISHED! Cambridge "SCN2A-Related Disorders" Written and edited by leading experts, this comprehensive review explores the clinical spectrum, genetics, and therapeutic advances surrounding SCN2A-related conditions. Open access made possible by FamilieSCN2A. www.scn2a.org/pdf/scn2arel...

Hot off the press. New article, "Charting the Course to a Cure for #SCN2A related disorders" was just published today in Therapeutic Advances in Rare Disease. journals.sagepub.com/doi/10.1177/.... #rareepilepsy #autism #patientadvocacy

New paper from @selinsch.bsky.social in collaboration with @alexkwan.bsky.social

doi.org/10.1523/ENEU...

Scn2a loss is a major ASD/ID risk, and it brings along comorbidities like epilepsy. Selin found that mouse models do just fine in foraging tasks, but the associated water restriction ⬆️ seizure

✨ Big News! ✨
Seize the Moment. Move Mountains for SCN2A!
We’re thrilled to announce that our 7th Family & Professional Conference is coming to Denver, Colorado on July 31-Aug 2, 2025! More details coming soon! 💙💚💜
#SCN2A #cureSCN2A #genetics #geneticeilepsy #autism #epilepsy